Our team has helped 100+ organizations secure and manage
$10B+ billion dollars in non-dilutive U.S. Government funding for R&D projects, including from DTRA and DTRA funded consortiums.
The Defense Threat Reduction Agency (DTRA)
develops solutions to enable the Department of Defense to prevent, reduce, and counter weapons-of-mass-destruction and emerging threats.
DTRA funds the development of vaccines, therapeutics, diagnostics, medical devices, and personal protective equipment (PPE). DTRA also collaborates with JPEO-CBRND to develop and implement CBRN defense strategies and capabilities for the warfighter.
These opportunities are typically available through Broad Agency Announcements (BAAs) and Requests for Proposals (RFPs) directly from DTRA or through industry consortiums including the Medical CBRN Defense Consortium (MCDC), the Medical Technology Enterprise Consortium (MTEC), and the Countering Weapons of Mass Destruction (CWMD) Consortium.
DTRA Consulting can help your organization navigate the DTRA (and JPEO-CBRND) funding landscape and put your potential project in the best position for a successful award.
*Identify relevant funding opportunities within the appropriate DTRA division or program:
*Facilitate project pitch meetings with DTRA and JPEO-CBRND stakeholders to gain valuable agency feedback.
*Prepare White Paper or Full Proposal applications for the potential project.
*Negotiate final funding award (e.g., FAR Contract, Cooperative Agreement, or Other Transaction):
*Post-award project management:
*Post-award compliance, contract administration, and financial management:
DTRA Consulting
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.